Royal Fund Management, LLC
Source: SEC Form 13F · as of Mar 2026Royal Fund Management, LLC holds 11 biotech & pharma companies tracked by BioSniper, totaling $50.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$50.4M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 47,838 | $10.3M |
| JNJJOHNSON & JOHNSON | 37,181 | $9.1M |
| MRKMerck & Co., Inc. | 68,809 | $8.3M |
| AMGNAMGEN INC | 21,119 | $7.4M |
| LLYELI LILLY & Co | 4,958 | $4.6M |
| BMYBRISTOL MYERS SQUIBB CO | 62,903 | $3.8M |
| PFEPFIZER INC | 80,508 | $2.3M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 35,541 | $2.0M |
| PMPhilip Morris International Inc | 10,804 | $1.8M |
| VKTXViking Therapeutics, Inc. | 20,976 | $683K |
| GILDGILEAD SCIENCES, INC. | 1,876 | $261K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.